Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 15, 2024

Total Value ($000): $178 (100.0% shares, 0.0% debt)

Holdings (13)

UTHR UNITED THERAPEUTICS CORP 20.1%
Value ($000) $36 Shares 100,332 Est. Cost $127.97 Unrealized +164.0%
EXEL EXELIXIS INC 18.6%
Value ($000) $33 Shares 1,281,612 Est. Cost $18.73 Unrealized +32.7%
CAH CARDINAL HEALTH INC 13.0%
Value ($000) $23 Shares 210,263 Est. Cost $56.53 Unrealized +81.0%
BIIB BIOGEN INC 12.3%
Value ($000) $22 Shares 113,502 Est. Cost $267.94 Unrealized -21.9%
ENTA ENANTA PHARMACEUTICALS INC 8.7%
Value ($000) $16 Shares 1,498,074 Est. Cost $27.36 Unrealized -52.2%
JAZZ JAZZ PHARMACEUTICALS PLC 6.9%
Value ($000) $12 Shares 110,257 Est. Cost $123.54 Unrealized -11.3%
BNTX BIONTECH SE-ADR 6.2%
Value ($000) $11 Shares 93,583 Est. Cost $0.09 Unrealized —
SNY SANOFI-ADR 4.9%
Value ($000) $9 Shares 150,205 Est. Cost $0.05 Unrealized —
ALKS ALKERMES PLC 3.9%
Value ($000) $7 Shares 251,495 Est. Cost $18.83 Unrealized +41.6%
— INDIVIOR PLC 3.8%
Value ($000) $7 Shares 701,873 Est. Cost $0.01 Unrealized —
VNDA VANDA PHARMACEUTICALS INC 1.1%
Value ($000) $2 Shares 414,684 Est. Cost $5.16 Unrealized +3.8%
REGN REGENERON PHARMACEUTICALS 0.2%
Value ($000) $0 Shares 353 Est. Cost $342.96 Unrealized +222.7%
— MURAL ONCOLOGY PLC 0.1%
Value ($000) $0 Shares 75,868 Est. Cost $0.01 Unrealized —